Summary
Glipizide stimulates insulin release from incubated pieces of rat pancreatic tissue. The dose-action relationship is characterized by an ED50 of approximately 0.04 μM, comparable to that of glibenclamide or glisoxepide. Like other sulphonylureas, the insulinotropic action of glipizide over 60 min incubation is barely detectable in the absence of glucose, maximal at intermediate glucose concentrations (1.0 to 1.5 mg/ml), and present but short-lived at a higher glucose level (3.0 mg/ml).
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Mandelli, V., Parenti, M.A., Rabini, T., Usardi, M. M., Tommasini, R.: Pharmacological study on a new oral antidiabetic: N-(4-[β-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl)-N′-cyclohexyl-urea or K 4024. Arzneimittel-Forsch.21, 208–213 (1971)
Brisson, G.R., Malaisse, W.J.: Insulinotropic effect and possible mode of action of a new potent sulfonylurea (BS-4231). Canad. J. Physiol. Pharmacol.49, 536–544 (1971)
Malaisse, W.J., Leclercq-Meyer, V.: Insulinotropic action of a new sulfonylurea: gliclazide. Rev. europ. étud. clin. biol.17, 310–314 (1972)
Malaisse, W.J., Malaisse-Lagae, F.: Effects of glycodiazin and glybenclamide upon insulin secretion in vitro. Europ. J. Pharmacol.9, 93–98 (1970)
Malaisse, W.J., Malaisse-Lagae, F., Mayhew, D.A., Wright, P.H.: Effects of sulfonylureas upon insulin secretion by the rat's pancreas. Excerpta Med. Found. ICS149, 49–60 (1967)
Malaisse, W., Malaisse-Lagae, F., Wright, P.H.: A new method for the measurement in vitro of pancreatic insulin secretion. Endocrinology80, 99–108 (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herchuelz, A., Malaisse, W.J. Insulinotropic potency of glipizide in vitro. Diabetologia 9 (Suppl 1), 309–310 (1973). https://doi.org/10.1007/BF01218439
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01218439